PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Epidermal Growth Factor Receptor 24,772 Target Target ERK1 18,374 662 0.03 -0.97 0.04 0.70
Albuminuria 6,831 Disease Target Renin 43,456 535 0.03 -0.95 0.08 0.69
CXCL16 341 Target Target CXCL7 76 5 0.03 -0.96 0.07 0.77
CD1A 2,739 Target Target CD4 112,219 547 0.03 -0.89 0.20 0.66
CCL18 256 Target Target CCL2 3,560 30 0.03 -0.94 0.12 0.73
Cancer 1,053,491 Disease Target BRAF 4,766 2,231 0.03 -0.73 0.47 0.62
Neck Pain 5,675 Disease Target C7 7,027 199 0.03 -0.97 0.04 0.73
Thrombocytopenia 35,805 Disease Target Bivalirudin 891 178 0.03 -0.89 0.20 0.69
CD4 112,219 Target Target CD95 4,266 691 0.03 -0.91 0.16 0.66
Rheumatoid Arthritis 78,952 Disease Target Collagen 138,882 3,319 0.03 -0.97 0.04 0.66
CCL4 5,638 Target Target CXCL9 1,016 76 0.03 -0.96 0.07 0.73
AMY2B 21 Target Target Pancreatic Alpha-Amylase 423 3 0.03 -0.92 0.14 0.76
Metastatic Breast Cancer 9,288 Disease Target CA 15-3 898 93 0.03 -0.94 0.10 0.72
CCL19 658 Target Target CXCL11 526 19 0.03 -0.97 0.04 0.77
CXCL11 526 Target Target CCL1 220 11 0.03 -0.96 0.05 0.77
Androgen Receptor 12,918 Target Target Estrogen Receptor Beta 1,924 163 0.03 -0.95 0.08 0.71
CCL5 2,002 Target Target CCL21 808 42 0.03 -0.96 0.05 0.75
CCL4 5,638 Target Target CXCL2 750 68 0.03 -0.95 0.09 0.73
CAMK2D 21 Target Target CAMK4 43 1 0.03 -0.96 0.05 0.80
Graft Versus Host Disease 15,741 Disease Target CD4 112,219 1,399 0.03 -0.95 0.09 0.67
Cancer 1,053,491 Disease Target Cox-2 21,583 5,031 0.03 -0.87 0.23 0.61
CXCL11 526 Target Target CXCL2 750 21 0.03 -0.97 0.04 0.77
Draflazine 33 Drug Target Ent2 108 2 0.03 -0.96 0.06 0.79
CCL14 34 Target Target Eotaxin-3/CCL26 26 1 0.03 -0.97 0.04 0.81
Collagen 138,882 Target Target BMP-2 3,889 783 0.03 -0.89 0.20 0.66
APOA1 958 Target Target APOE 12,771 118 0.03 -0.93 0.12 0.71
Hyperbilirubinemia 5,757 Disease Target Udp-Glucuronosyltransferase 2,219 121 0.03 -0.96 0.05 0.74
Tissue-Type Plasminogen Activator 5,020 Target Target Antithrombin 13,773 282 0.03 -0.96 0.06 0.72
CXCL10 2,386 Target Target CXCL4/PF4 9 5 0.03 -0.67 0.56 0.72
CER 2,421 Target Target Sphingomyelinase 3,060 93 0.03 -0.97 0.04 0.75
CCL19 658 Target Target CCL2 3,560 53 0.03 -0.95 0.08 0.74
CCL2 3,560 Target Target CXCL11 526 48 0.04 -0.95 0.09 0.74
CXCL9 1,016 Target Target CCL21 808 32 0.04 -0.96 0.04 0.77
EPHA2 532 Target Target EPHB2 385 16 0.04 -0.96 0.04 0.78
CXCL16 341 Target Target CXCL11 526 15 0.04 -0.96 0.04 0.78
Angiotensin Converting Enzyme 31,674 Target Target Aldosterone Receptor 528 146 0.04 -0.85 0.28 0.69
Tubulin Beta-1 Chain 3 Target Target Inosine-5'-Monophosphate Dehydrogenase 261 1 0.04 -0.81 0.33 0.76
CXCL7 76 Target Target CCL5 2,002 14 0.04 -0.90 0.18 0.74
Diabetes 332,602 Disease Target Angiotensin Converting Enzyme 31,674 3,701 0.04 -0.93 0.12 0.64
EPHA3 140 Target Target EPHB1 137 5 0.04 -0.96 0.04 0.80
CD4 112,219 Target Target CD154 1,512 477 0.04 -0.83 0.32 0.67
CXCL10 2,386 Target Target CCL21 808 51 0.04 -0.96 0.06 0.75
CCL19 658 Target Target CCL3 1,427 36 0.04 -0.96 0.05 0.76
Neutral Alpha-Glucosidase C 6 Target Target Alpha-Glucosidase 4,319 6 0.04 -0.38 1.00 0.72
EPHB4 329 Target Target EPHA3 140 8 0.04 -0.96 0.06 0.78
CCL19 658 Target Target CXCL10 2,386 47 0.04 -0.95 0.07 0.75
CCL18 256 Target Target CCL1 220 9 0.04 -0.96 0.04 0.80
CCL3 1,427 Target Target CXCL11 526 33 0.04 -0.96 0.06 0.76
CXCL7 76 Target Target CXCL4/PF4 9 1 0.04 -0.94 0.11 0.79
Epidermal Growth Factor Receptor 24,772 Target Target ERBB4 994 191 0.04 -0.90 0.19 0.70